難溶性薬物(R)-1-[2,3-Dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea(YM022)の結晶形の検討及び溶解性, 吸収性改善について

概要

論文の詳細を見る
Polymorphs of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl) urea (YM022) were investigated. Two crystalline forms (α-and β-forms) of YM022 were confirmed by powder X-ray diffractometry and differential scanning calorimetry. α-And β-forms were obtained by recrystallization from ethanol and ethanol : water (5 : 1), respectively. Amorphous YM022 was obtained by spray drying of YM022 methanol solution. Since both crystalline and amorphous YM022 were sparingly soluble in water, solubilization of YM022 by solid dispersion and wet grinding methods were performed. In vitro dissolution study and in vivo absorption study in dogs were carried out using spray-dried solid dispersion, heat-treated solid dispersion and mechanical mixture. Spray-dried solid dispersion, heat-treated solid dispersion and mechanced mixture. Spray-dried solid dispersion and heat-treated solid dispersion showed enhanced bioavailability, whereas mechanical mixture showed no improvement.
社団法人日本薬学会の論文
1996-08-25